This compound, (3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4-(benzyloxy)phenyl]-3-azetidinepropanoic acid methyl ester, is a key chiral β-lactam (azetidinone) intermediate. It features a 4-phenylazetidinone core substituted with a 4-fluorophenyl group and a propanoic acid methyl ester side chain, with the benzyloxy group serving as a common protecting group. Its primary and well-documented application is in the synthesis of Ezetimibe, a widely prescribed cholesterol absorption inhibitor used to treat hypercholesterolemia. The (3R,4S) stereochemistry of this intermediate is crucial for the biological activity of the final API. The synthesis route involving this compound is a critical step in constructing the pharmacologically active azetidinone core of Ezetimibe. As a specialized chiral building block, its use is almost exclusively tied to pharmaceutical manufacturing processes for this specific drug. It is not a general-purpose synthetic reagent. Handling requires standard precautions for fine chemicals in a controlled laboratory or production environment.